SEIKAGAKU BIOBUSINESS
Live / Registered — International registration cancelled — extension of protection cancelled (as of 14 Mar 2019)
What this means for you
Registered since 30 Apr 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79071476
- Registration number
- 4326258
- Mark type
- Stylized text
- Filed
- 13 Mar 2009
- Published for opposition
- 12 Feb 2013
- Registered
- 30 Apr 2013
- Attorney of record
- Howard N. Aronson
Goods and services
- Class 001 — Chemicals: Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins and beta-glucan; Reagents for scientific medical research and quality control testing use, namely, for use in determining the presence of analytes in or on water, pharmaceutical products, medical devices, dialysate, blood, blood components, body fluids, and tissues; Reagents for clinical or medical laboratory use, namely, glycobiological analysis reagents and diagnostic preparations and reagents for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Joint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Submucosal injection materials for endoscopes used for the treatment of dissecting and resecting tumors and cancer, namely, submucosal injectable preparations for treatment of dissecting and resecting tumors and cancer; Pharmaceutical preparations for the treatment of disc hernia; Syringes sold filled with crosslinked or non-crosslinked hyaluronic acid based gel; Syringes sold filled with sodium hyaluronate solutions; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes
- Class 009 — Scientific and electric apparatus: Laboratory apparatus and instruments for use in performing assays of endotoxin and beta-glucan concentrations, namely, spectrophotometers, test tubes, reaction tubes, assay microplates, pipette tips, 96-well microplates, reagent reservoirs, transfer pipettes, sample containers; Laboratory apparatus and instruments for use in measuring absorbance and turbidity and interpreting the results, namely, density meters, concentration meters; Laboratory apparatus and instruments for use in analyzing urine, namely, clinical laboratory analyzers for measuring, testing and analyzing urine; Laboratory apparatus and instruments, namely, chemical and biochemical analytical instruments in the nature of laboratory chemical reactors, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Electronic machines, apparatus and their parts, namely, clinical chemistry analyzers for laboratory use in the analysis of biological samples; Magnetic media with recorded programs, namely, pre-recorded magnetic media featuring computer programs used to control and collect data from optical readers, and to analyze data and generate reports for use in the field of endotoxin and beta-glucan analysis
Owner
Prosecution history
- 04 Oct 2019 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 04 Oct 2019 — DEATH OF INTERNATIONAL REGISTRATION
- 30 Apr 2018 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 15 Aug 2014 — NEW REPRESENTATIVE AT IB RECEIVED
- 24 Jan 2014 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 09 Jan 2014 — FINAL DISPOSITION NOTICE SENT TO IB
- 09 Jan 2014 — FINAL DISPOSITION PROCESSED
- 30 Jul 2013 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Apr 2013 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2013 — NOTIFICATION PROCESSED BY IB
- 12 Feb 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Feb 2013 — PUBLISHED FOR OPPOSITION
- 23 Jan 2013 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Jan 2013 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 23 Jan 2013 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED